Although the pathogenic potential of Blastocystis hominis in human enteric disease had been reported in the older literature (2, 3, 9, 15) , most of the recent textbooks describe it as a commensal found frequently in fecal specimens (7, 10, 17) . Despite occasional case reports since 1976 regarding its association with human disease (4, 6, 13, 18) , many physicians and clinical microbiologists consider its presence in stool specimens to be of questionable significance (8, 11) . Recently, Sheehan et al. (16) and Babcock et al. (1) described the association of human disease with the presence of B. hominis in stool specimens of several patients and emphasized the need for further studies to elucidate its role and effective therapies. Since we have observed B. hominis in stool specimens of 647 patients in the last 2 years, we decided to undertake a retrospective chart review of these patients. Our findings are presented in this report.
( 
RESULTS
Over a 2-year period, 19,252 consecutive stool specimens from 12,136 patients were examined at KFSH&RC for the presence of intestinal parasites. KFSH&RC is a 500-bed tertiary-care referral hospital with admissions of 27,842 patients and an outpatient volume of 698,469 during the period of this study. Of the 2,889 patients with intestinal parasites, 647 had B. hominis. The medical charts of these patients were reviewed for the presence of other pathogens, pertinent laboratory findings, symptoms, underlying disease, therapy, and follow-up. B. hominis was found in association with other organisms in 359 patients (Table 1) ; 132 had potentially pathogenic protozoan and metazoan parasites, Campylobacter jejuni, and Shigella flexneri; 227 had commensals. The former group was excluded from further follow-up for obvious reasons of difficulty in interpreting the data in terms of attributing any symptoms to B. hominis.
Of the remaining 515 patients harboring B. hominis, the male-to-female ratio was about 1; and 8.9% of the infestations were in children and 19.3% were in patients over 50 years old (Table 2) . No enteric symptoms were found in 55.6% of the patients. Large numbers (more than three to five organisms per 40X field) of B. hominis cells were found as the only pathogen in 107 of the 239 patients with symptoms and in association with nonpathogenic parasites in 132 of these patients. The most common symptom was found to be abdominal pain, followed by constipation, diarrhea, and others (Table 3) . Medical chart review showed that eosinophilia (9 to 11%) was present in 22 of these patients. ................................... found that 21, 24, and 55% of specimens had few, moderate, and many organisms, respectively. Sheehan et al. (16) (16) , with abdominal discomfort (79%) being the most frequent complaint, followed by anorexia (53%), diarrhea (52%), and flatus (52%). Excluding the specimens containing known human pathogens, 239 (46.4%) of the 515 patients in our study had signs and symptoms of human disease. Eighty-nine percent of these patients had large numbers of B. hominis cells in the stools. As in the study of Sheehan et al. (16) , the most frequent symptom was abdominal pain (88%). However, in our patients the second most common complaint was constipation (32%), followed by diarrhea and constipation (15%) and others.
Despite the presence of symptoms in 239 patients with B. hominis alone or in association with commensals, only 43 patients were treated with metronidazole. Resolution of symptoms accompanied by the absence ofB. hominis cells in stool on follow-up examinations in all cases resulted after 7 to 10 days of therapy. Similar responses to metronidazole in four patients were described in the recent literature (5, 6, 14, 18) .
Our study supports the emerging view that B. hominis should be considered as a causative agent of human disease in patients with recurrent symptoms, especially when the parasite is present in large numbers in fecal specimens in the absence of other known pathogens. Until recently, our laboratory reports sent to clinicians of harmless intestinal parasites, such as Entamoeba coli, Chilomastix mesnili, and others, included the statement that "the organisms) reported are generally considered as non-pathogenic." We have discontinued this practice for B. hominis.
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